Table 4.

The relationship between AIP and the progression from normoglycemia to pre-DM in different competing risk models.

Exposure	Crude model (SHR, 95% CI, P)	Model I (SHR, 95% CI, P)	Model II (SHR, 95% CI, P)
AIP (per 0.1 unit)	1.21 (1.16, 1.25) < 0.001	1.12 (1.08, 1.17) < 0.001	1.09 (1.04, 1.14) < 0.001
AIP quartiles
Q1	Ref.	Ref.	Ref.
Q2	2.38 (1.48, 3.84) < 0.001	1.75 (1.08, 2.83) 0.023	1.61 (0.99, 2.61) 0.055
Q3	4.16 (2.67, 6.50) < 0.001	2.53 (1.60, 4.00) < 0.001	2.18 (1.37, 3.47) 0.001
Q4	5.91 (3.83, 9.10) < 0.001	3.01 (1.92, 4.74) < 0.001	2.29 (1.44, 3.65) < 0.001
P for trend	<0.001	<0.001	<0.001

Crude Model: We did not adjust other covariates.

Model I: We adjust sex and age.

Model II: We adjust sex, drinking status, BMI, age, Hs-CRP, ALT, SBP, physical activity, smoking status, Scr, GGT, LDL-c, AST, hypertension, DLP-MED, and HTN-MED.

SHR, sub-distribution hazard ratio; Ref, reference; CI, confidence interval.